Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 125.86 Million CNY | -46.29% |
| 2022 | 234.35 Million CNY | -22.0% |
| 2021 | 300.44 Million CNY | -90.02% |
| 2020 | 3.01 Billion CNY | 82.22% |
| 2019 | 1.65 Billion CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 86.31 Million CNY | -31.43% |
| 2024 Q2 | 86.31 Million CNY | 0.0% |
| 2023 Q2 | 111.58 Million CNY | 0.0% |
| 2023 FY | 125.86 Million CNY | -46.29% |
| 2023 Q4 | 125.86 Million CNY | 0.0% |
| 2023 Q1 | 111.58 Million CNY | -52.39% |
| 2023 Q3 | 125.86 Million CNY | 12.8% |
| 2022 Q1 | 321.13 Million CNY | 6.89% |
| 2022 FY | 234.35 Million CNY | -22.0% |
| 2022 Q4 | 234.35 Million CNY | 0.0% |
| 2022 Q3 | 234.35 Million CNY | -27.02% |
| 2022 Q2 | 321.13 Million CNY | 0.0% |
| 2021 Q1 | 6.3 Billion CNY | 109.46% |
| 2021 FY | 300.44 Million CNY | -90.02% |
| 2021 Q2 | 6.3 Billion CNY | 0.0% |
| 2021 Q3 | 300.44 Million CNY | -95.24% |
| 2021 Q4 | 300.44 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 3.01 Billion CNY | 82.22% |
| 2020 Q4 | 3.01 Billion CNY | 0.0% |
| 2020 Q3 | 3.01 Billion CNY | 0.0% |
| 2019 FY | 1.65 Billion CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -136.13% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -1213.595% |
| SQZ Biotechnologies Company | 50.03 Million USD | -151.542% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -73.682% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -113.287% |
| Mesoblast Limited | 188.44 Million USD | 33.206% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -3168.116% |
| Genus plc | 485 Million USD | 74.048% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -2054.324% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -4902.09% |
| Marizyme, Inc. | 26.67 Million USD | -371.849% |
| ContraFect Corporation | 32.53 Million USD | -286.92% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -3212.342% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -6252.823% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -3188.416% |
| Intellipharmaceutics International Inc. | 12 Million USD | -948.143% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -968.661% |
| MultiCell Technologies, Inc. | 1617.67 USD | -7780782.38% |
| Accustem Sciences Inc. | 1.07 Million USD | -11562.755% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -62.586% |
| EV Biologics, Inc. | 2.11 Million USD | -5851.059% |
| Q BioMed Inc. | 8.13 Million USD | -1447.645% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -51.768% |
| Neon Bloom, Inc. | 1.22 Million USD | -10164.856% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -2345.941% |
| Biomind Labs Inc. | 1.49 Million USD | -8299.039% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | 48.43% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -583.944% |
| Skye Bioscience, Inc. | 14.07 Million USD | -794.45% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -6161.734% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -88480.879% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -1229.707% |
| IMV Inc. | 37.93 Million USD | -231.821% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -62485.274% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -2090.618% |
| GB Sciences, Inc. | 5.41 Million USD | -2223.353% |
| Alpha Cognition Inc. | 7.16 Million USD | -1656.776% |
| HST Global, Inc. | 593.59 Thousand USD | -21104.596% |
| CSL Limited | 18.62 Billion USD | 99.324% |
| Halberd Corporation | 728.71 Thousand USD | -17172.639% |
| Enzolytics Inc. | 365.26 Million USD | 65.541% |
| Resverlogix Corp. | 67.39 Million USD | -86.76% |
| Affymax, Inc. | 8.87 Million USD | -1318.882% |
| SYBLEU INC | 681.41 Thousand USD | -18371.764% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -14907.058% |
| argenx SE | 444.95 Million USD | 71.712% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -68.005% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -7243.582% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -957.447% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -3334.198% |
| AVAX Technologies, Inc. | 3.99 Million USD | -3051.653% |
| Zenith Capital Corp. | 27.56 Thousand USD | -456459.904% |
| Genscript Biotech Corporation | 1.32 Billion USD | 90.507% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -52641.207% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -3270.613% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -18387.473% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -6.02% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -1292.018% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -187963.47% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -8678.326% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -150.416% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -4541.802% |
| BioStem Technologies, Inc. | 15.9 Million USD | -691.397% |
| ONE Bio Corp. | 27.49 Million USD | -357.775% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -26986.135% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -458723.315% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -9896.005% |
| Agentix Corp. | 2.51 Million USD | -4913.593% |
| LadRx Corporation | 2.2 Million USD | -5619.945% |
| Cell Source, Inc. | 15.8 Million USD | -696.301% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -281511.33% |
| Regen BioPharma, Inc. | 5.45 Million USD | -2206.3% |
| Regen BioPharma, Inc. | 5.45 Million USD | -2206.3% |
| NovAccess Global Inc. | 7.86 Million USD | -1501.238% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -408.643% |
| Itoco Inc. | 1.65 Million USD | -7513.884% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -6035.267% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -1980.823% |
| Kadimastem Ltd | 3.5 Million USD | -3491.263% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -29757.342% |
| CytoDyn Inc. | 127.89 Million USD | 1.583% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -301029.214% |
| Mobile Lads Corp. | 1.31 Million USD | -9482.74% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -7935.677% |
| Qrons Inc. | 1.48 Million USD | -8354.887% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -1039.572% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -15462.554% |
| Rebus Holdings, Inc. | 5.24 Million USD | -2301.164% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -1962.782% |
| International Stem Cell Corporation | 5.27 Million USD | -2285.238% |
| Bioxytran, Inc. | 3.24 Million USD | -3773.488% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -20013.006% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -2626.134% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -207.028% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -465.322% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -6114.565% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -2197.718% |
| Neutra Corp. | 973.52 Thousand USD | -12829.147% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -333.807% |
| PureTech Health plc | 125.58 Million USD | -0.228% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -3250.141% |
| IXICO plc | 1.9 Million USD | -6523.666% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -513.128% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -21.82% |
| CSL Limited | 18.62 Billion USD | 99.324% |
| Cellectis S.A. | 249.36 Million USD | 49.525% |